Literature DB >> 3306909

Methodological issues facing the interpretation of high-risk studies: biological heterogeneity.

D L Garver.   

Abstract

High-risk studies provide a unique opportunity to examine the interaction of biological vulnerability and psychosocial factors in the development of the major psychiatric illnesses. To parcel out the effects of psychosocial variables, high-risk populations need to be separated into offspring who are and who are not biologically/genetically vulnerable, since psychosocial modifiers will be interactive only in the biologically vulnerable offspring. Criteria are suggested for the use of "biological markers" to detect subjects at genetic/biological risk within high-risk cohorts. Presently, only the d' statistic of the continuous performance test (CPT) appears to satisfy the criteria for identification of such biologically vulnerable offspring.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306909     DOI: 10.1093/schbul/13.3.525

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  4 in total

1.  Startle during threat longitudinally predicts functional impairment independent of DSM diagnoses.

Authors:  Elizabeth S Stevens; Lynne Lieberman; Carter J Funkhouser; Kelly A Correa; Stewart A Shankman
Journal:  Psychiatry Res       Date:  2019-03-08       Impact factor: 3.222

Review 2.  Identification of the phenotype in psychiatric genetics.

Authors:  M T Tsuang; S V Faraone; M J Lyons
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

3.  Neural Correlates of Semantic Inhibition in Relation to Hypomanic Traits: An fMRI Study.

Authors:  Delphine Raucher-Chéné; Sarah Terrien; Fabien Gierski; Alexandre Obert; Stéphanie Caillies; Chrystel Besche-Richard; Arthur Kaladjian
Journal:  Front Psychiatry       Date:  2018-04-04       Impact factor: 4.157

Review 4.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.